Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Jan 18, 2018, 07:00 ET Bluegrass Vascular Announces Enrollment Of First Patients In U.S. Pivotal Trial

Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access,...


Jan 18, 2018, 04:48 ET Add-on en aanspraak voor Eisai's Kisplyx® (lenvatinib) voor de behandeling van gevorderd niercel carcinoom

ALLEEN VOOR NL-MEDIA Eisai BV maakt bekend dat vanaf 1 december 2017 een add-on en aanspraak is toegekend aan Kisplyx® (lenvatinib) in...


Jan 18, 2018, 03:00 ET Biohaven Announces Initiation Of Clinical Development For BHV-5000, A Novel Low-Trapping NMDA Antagonist

Biohaven Pharmaceutical Holding Company Ltd. (Biohaven or the "Company") and its wholly owned subsidiary, Biohaven Pharmaceuticals, Inc., today...


Jan 17, 2018, 19:00 ET GC Pharma Confirms Phase 2/3 Clinical Trial of New Protein Therapy for Hepatitis B

GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced that it will proceed...


Jan 17, 2018, 16:09 ET Overall Survival Analysis From KYPROLIS® (Carfilzomib) Phase 3 ASPIRE Trial Published in the Journal of Clinical Oncology

Amgen (NASDAQ:AMGN) today announced that the Journal of Clinical Oncology published positive overall survival (OS) findings from the final analysis...


Jan 17, 2018, 15:37 ET Researchers Discover Structure of Anti-Aging Hormone

A new study reveals the molecular structure of a protein called alpha(α)Klotho, and how it helps to transmit a hormonal signal that slows...


Jan 17, 2018, 14:28 ET OBI Pharma erhält FDA-Genehmigung des IND-Antrags auf Phase-1-Studie eines monoklonalen Antikörpers zur Krebsimmuntherapie (OBI-888).

In erster klinischer Studie werden Sicherheit und vorläufige Aktivität einer passiven Immuntherapie auf Basis eines monoklonalen Antikörpers...


Jan 17, 2018, 10:57 ET Celsee and IncellDx Sign Co-Commercialization Agreement Following Successful Lung Cancer/CTC PD-L1 Feasibility Study

Celsee, Inc., an innovator of platforms for comprehensive single-cell identification, analysis and retrieval, announced today that they have...


Jan 17, 2018, 09:15 ET MiMedx Announces the Enrollment of the First Patients in the Phase 3 Clinical Trial of AmnioFix® Injectable for Achilles Tendonitis

MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing...


Jan 17, 2018, 09:10 ET First Duchenne Muscular Dystrophy Patient Dosed in Systemic Microdystrophin Gene Therapy

Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), announced that...


Jan 17, 2018, 09:01 ET MobileODT Technology Improves Cervical Cancer Detection Rates - Study

As per a new World Bank/IFC-funded study by MobileODT and Apollo Hospitals, deploying the EVA (Enhanced Visual Assessment) System at primary...


Jan 17, 2018, 09:00 ET Neurim Pharmaceuticals' New Paediatric Prolonged-Release Melatonin ("PedPRM") to Be Marketed by BIOCODEX Oy in Finland

Neurim Pharmaceuticals ('Neurim') and BIOCODEX Oy ('Biocodex') announced today a license agreement in which Biocodex will obtain the exclusive...


Jan 17, 2018, 08:28 ET Technology Advancements to Conquer the Precision Medicine Market

Chimeric Antigen Receptor (CAR) T Cell therapy prove effective in treating hematological cancers, with close to 90% clinical response rate...


Jan 17, 2018, 08:10 ET OBI Pharma annonce que la FDA a approuvé une demande d'IND pour une étude de phase 1 d'immunothérapie du cancer par anticorps monoclonaux (OBI-888)

Premiers essais cliniques pour tester l'innocuité et l'activité préliminaire de l'immunothérapie passive reposant sur des anticorps monoclonaux...


Jan 17, 2018, 08:00 ET Regen BioPharma, Inc.'s Medicinal Chemistry Program has Identified Additional Compounds That Activate NR2F6

Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP) continues to develop small molecule drugs that activate NR2F6 and has identified a key...


Jan 17, 2018, 08:00 ET Bayer to Highlight New Research at ASCO GI 2018 Cancer Symposium

Bayer announced today that new data from the continued research on Stivarga® (regorafenib) and Nexavar® (sorafenib) in advanced liver, colorectal...


Jan 17, 2018, 07:00 ET BioLineRx Announces Partial Monotherapy Results from Phase 2a COMBAT Study in Pancreatic Cancer

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today partial...


Jan 17, 2018, 07:00 ET Curis Announces Initiation of Phase 1 Trial of CA-4948, a Small Molecule Inhibitor of IRAK4 Kinase in Patients with Lymphoma

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative and effective...


Jan 17, 2018, 05:00 ET OBI Pharma Announces FDA Clearance Of IND Application For A Phase 1 Study Of A Monoclonal Antibody Cancer Immunotherapy (OBI-888).

OBI Pharma, Inc., a Taiwan biopharma company (TPEx: 4174), today announced that the U.S. Food and Drug Administration (FDA) has cleared an...


Most Viewed